Drug Therapy Combo May Have Led to Toxic Epidermal Necrolysis in Multiple Myeloma Patient
Multiple myeloma patients taking the immunomodulatory drug thalidomide may…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Oral 3-Drug Combo Looks Promising in Treatment-Resistant Myeloma
Combining three well-known oral drugs shows potential for heavily pretreated…
Kyprolis Combo Seen to Improve Life Quality in Relapsed Multiple Myeloma Patients
Adding the proteasome inhibitor Kyprolis (carfilzomib) to the standard…
Phase 3 Trial Will Assess Darzalex-containing Combo Therapy in Multiple Myeloma Patients
The anti-CD38 agent Darzalex (daratumumab) will be investigated in…
FDA Places Hold on BioInvent’s Phase 2 Trial for Multiple Myeloma Therapy
The U.S. Food and Drug Administration (FDA) has verbally…
Karyopharm to Present Updated Clinical Data of Selinexor in Multiple Myeloma Patients
Karyopharm Therapeutics is set to present novel clinical…
